HA
MRK icon

Huntleigh Advisors’s Merck MRK Stock Holding History

Huntleigh Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
3,958
+457
+13% +$52.8K 0.08% 182
2025
Q4 		$369K Sell
3,501
-122
-3% -$11.5K 0.06% 197
2025
Q3 		$304K Sell
3,623
-90
-2% -$7.41K 0.05% 214
2025
Q2 		$294K Sell
3,713
-18
-0.5% -$1.43K 0.06% 209
2025
Q1 		$335K Sell
3,731
-8,090
-68% -$755K 0.08% 174
2024
Q4 		$1.18M Buy
+11,821
New +$1.22M 0.25% 84

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Huntleigh Advisors's MRK Position: Q1 2026 in Review

Huntleigh Advisors increased its Merck (MRK) stake by 13% in Q1 2026, buying an estimated $52.8K and bringing the position to 3,958 shares worth $476K. The position accounts for 0.08% of the portfolio, ranked #182.

Huntleigh Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.18M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Huntleigh Advisors held 3,958 shares of Merck worth $476K as of Q1 2026.
  • Huntleigh Advisors bought 457 Merck shares in Q1 2026, an estimated $52.8K.
  • Merck made up 0.08% of Huntleigh Advisors's portfolio in Q1 2026, its #182 holding.
  • Huntleigh Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Huntleigh Advisors's Merck position peaked at $1.18M in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Huntleigh Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.